{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:05:08Z","timestamp":1780099508630,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Although antihistamines and topical corticosteroids are used in combination to treat allergic rhinitis, their additive effect has not been yet demonstrated. The aim was investigate the antiinflammatory additive effect of mometasone and desloratadine on cytokine and sICAM-1 secretion by epithelial cells, and on eosinophil survival stimulated by human epithelial cells secretions from nasal mucosa and polyps.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Epithelial cells obtained from nasal mucosa or polyps were stimulated with 10% fetal bovine serum in presence of mometasone (10<jats:sup>-11<\/jats:sup>M-10<jats:sup>-5<\/jats:sup>M) with\/without desloratadine (10<jats:sup>-5<\/jats:sup>M). Cytokine and sICAM-1 concentrations in supernatants were measured by ELISA. Peripheral blood eosinophils were incubated during 4 days with epithelial cell secretions with (10<jats:sup>-11<\/jats:sup>M-10<jats:sup>-5<\/jats:sup>M) and\/or desloratadine (10<jats:sup>-5<\/jats:sup>M) and survival assessed by Trypan blue. Results are expressed as percentage (mean \u00b1 SEM) compared to control.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Fetal bovine serum stimulated IL-6, IL-8, GM-CSF and sICAM-1 secretion. In mucosa and polyp epithelial cells, mometasone inhibited this induced secretion while desloratadine inhibited IL-6 and IL-8. The combination of 10<jats:sup>-5<\/jats:sup>M desloratadine and 10<jats:sup>-9<\/jats:sup>M mometasone reduced IL-6 secretion (48 \u00b1 11%, p &lt; 0.05) greater extent than mometasone alone (68 \u00b1 10%) compared to control (100%). Epithelial cell secretions induced eosinophil survival from day 1 to 4, this effect being inhibited by mometasone. At day 4, the combination of mometasone (10<jats:sup>-11<\/jats:sup>M) and desloratadine (10<jats:sup>-5<\/jats:sup>M) provoked an increased inhibition of eosinophil survival induced by cell secretions (27 \u00b1 5%, p &lt; 0.01) than mometasone (44 \u00b1 7%) or desloratadine (46 \u00b1 7%) alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These results suggest that the combination of desloratadine and mometasone furoate have a greater antinflammatory effect in an in vitro model of eosinophil inflammation than those drugs administered alone.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1465-9921-12-23","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T19:18:57Z","timestamp":1300303137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells"],"prefix":"10.1186","volume":"12","author":[{"given":"Joaquim","family":"Mullol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"de Borja Callejas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Asunci\u00f3n","family":"Mart\u00ednez-Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"M\u00e9ndez-Arancibia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isam","family":"Alobid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pujols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Valero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Roca-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,1]]},"reference":[{"key":"1052_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2500\/105065800781329573","volume":"14","author":"C Bachert","year":"2000","unstructured":"Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P: Nasal polyposis: from cytokines to growth. Am J Rhinol. 2000, 14: 279-290. 10.2500\/105065800781329573.","journal-title":"Am J Rhinol"},{"key":"1052_CR2","first-page":"1","volume":"20","author":"W Fokkens","year":"2007","unstructured":"Fokkens W, Lund V, Mullol J: European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007, 20: 1-136.","journal-title":"Rhinol Suppl"},{"key":"1052_CR3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1378\/chest.08-0485","volume":"134","author":"JA Denburg","year":"2008","unstructured":"Denburg JA, Keith PK: Eosinophil progenitors in airway diseases: clinical implications. Chest. 2008, 134: 1037-1043. 10.1378\/chest.08-0485.","journal-title":"Chest"},{"key":"1052_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1164\/ajrccm.149.2.8306027","volume":"149","author":"TC Sim","year":"1994","unstructured":"Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R: Proinflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med. 1994, 149: 339-344.","journal-title":"Am J Respir Crit Care Med"},{"key":"1052_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1034\/j.1399-3038.1999.00036.x","volume":"10","author":"M Benson","year":"1999","unstructured":"Benson M, Strannegard IL, Wennergren G, Strannegard O: Interleukin-5 and interleukin-8 in relation to eosinophils and neutrophils in nasal fluids from school children with seasonal allergic rhinitis. Pediatr Allergy Immunol. 1999, 10: 178-185. 10.1034\/j.1399-3038.1999.00036.x.","journal-title":"Pediatr Allergy Immunol"},{"key":"1052_CR6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jaci.2009.10.072","volume":"125","author":"AT Peters","year":"2010","unstructured":"Peters AT, Kato A, Zhang N, Conley DB, Suh L, Tancowny B, Carter D, Carr T, Radtke M, Hulse KE, Seshadri S, Chandra R, Grammer LC, Harris KE, Kern R, Schleimer RP: Evidence for altered activity of the IL-6 pathway in chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2010, 125: 397-403. 10.1016\/j.jaci.2009.10.072.","journal-title":"J Allergy Clin Immunol"},{"key":"1052_CR7","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1365-2222.1995.tb01108.x","volume":"25","author":"J Mullol","year":"1995","unstructured":"Mullol J, Xaubet A, Gaya A, Roca-Ferrer J, Lopez E, Fernandez JC, Fern\u00e0ndez MD, Picado C: Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy. 1995, 25: 607-615. 10.1111\/j.1365-2222.1995.tb01108.x.","journal-title":"Clin Exp Allergy"},{"key":"1052_CR8","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/thx.50.3.270","volume":"50","author":"J Mullol","year":"1995","unstructured":"Mullol J, Xaubet A, L\u00f3pez E, Roca-Ferrer J, Picado C: Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. Thorax. 1995, 50: 270-274. 10.1136\/thx.50.3.270.","journal-title":"Thorax"},{"key":"1052_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/j.1365-2222.1997.tb02988.x","volume":"27","author":"J Mullol","year":"1997","unstructured":"Mullol J, L\u00f3pez E, Roca-Ferrer J, Xaubet A, Pujols L, Fern\u00e0ndez-Morata JC, Fabra JM, Picado C: Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium. Clin Exp Allergy. 1997, 27: 1432-1441. 10.1111\/j.1365-2222.1997.tb02988.x.","journal-title":"Clin Exp Allergy"},{"key":"1052_CR10","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1034\/j.1398-9995.1999.00251.x","volume":"54","author":"M Juan","year":"1999","unstructured":"Juan M, Mullol J, Roca-Ferrer J, Fuentes M, P\u00e9rez M, Vilardell C, Yag\u00fce J, Picado C: Regulation of ICAM-3 and other adhesion molecule expressions on eosinophils in vitro. Effects of dexamethasone. Allergy. 1999, 54: 1293-1298. 10.1034\/j.1398-9995.1999.00251.x.","journal-title":"Allergy"},{"key":"1052_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1053\/rmed.1999.0756","volume":"94","author":"J Mullol","year":"2000","unstructured":"Mullol J, Roca-Ferrer J, Xaubet A, Traserra J, Picado C: Inhibition of GM-CSF secretion by topical corticosteroids and nedocromil sodium. A comparison study using nasal polyp epithelial cells:. Respir Med. 2000, 94: 428-431. 10.1053\/rmed.1999.0756.","journal-title":"Respir Med"},{"key":"1052_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-2222.2005.02403.x","volume":"36","author":"J Mullol","year":"2006","unstructured":"Mullol J, Roca-Ferrer J, Alobid I, Pujols L, Valero A, Xaubet A, Bernal-Sprekelsen M, Picado C: Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival. Clin Exp Allergy. 2006, 36: 52-58. 10.1111\/j.1365-2222.2005.02403.x.","journal-title":"Clin Exp Allergy"},{"key":"1052_CR13","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.jaci.2005.07.027","volume":"116","author":"CB Small","year":"2005","unstructured":"Small CB, Hernandez J, Reyes A, Schenkel E, Damiano A, Stryszak P, Staudinger H, Danzig M: Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol. 2005, 116: 1275-1281. 10.1016\/j.jaci.2005.07.027.","journal-title":"J Allergy Clin Immunol"},{"key":"1052_CR14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2500\/aap.2009.30.3238","volume":"30","author":"R Anolik","year":"2009","unstructured":"Anolik R, Pearlman D, Teper A, Gates D: Mometasone furoate improves nasal and ocular symptoms of seasonal allergic rhinitis in adolescents. Allergy Asthma Proc. 2009, 30: 406-412. 10.2500\/aap.2009.30.3238.","journal-title":"Allergy Asthma Proc"},{"key":"1052_CR15","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1053\/rmed.2001.1061","volume":"95","author":"A Xaubet","year":"2001","unstructured":"Xaubet A, Mullol J, Roca-Ferrer J, Pujols L, Fuentes M, Perez M, Fabra JM, Picado C: Effect on budesonide and nedocromil sodium on IL-8 and IL-6 release from human nasal mucosa and polyp epithelial cells. Respir Med. 2001, 95: 408-414. 10.1053\/rmed.2001.1061.","journal-title":"Respir Med"},{"key":"1052_CR16","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1183\/09031936.97.10071489","volume":"10","author":"J Roca-Ferrer","year":"1997","unstructured":"Roca-Ferrer J, Mullol J, Lopez E, Xaubet A, Pujols L, Fernandez JC, Picado C: Effect of topycal anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion. Eur Respir J. 1997, 10: 1489-1495. 10.1183\/09031936.97.10071489.","journal-title":"Eur Respir J"},{"key":"1052_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0014-2999(01)01332-2","volume":"429","author":"M Kagoshima","year":"2001","unstructured":"Kagoshima M, Wilcke T, Ito K, Tsaprouni L, Barnes PJ, Punchard N, Adcock IM: Glucocorticoid-mediated transrepression is regulated by histone acetylation and DNA methylation. Eur J Pharmacol. 2001, 429: 327-334. 10.1016\/S0014-2999(01)01332-2.","journal-title":"Eur J Pharmacol"},{"key":"1052_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3109\/08923979109019704","volume":"13","author":"BE Barton","year":"1991","unstructured":"Barton BE, Jakway JP, Smith SR, Siegel MI: Cytokine inhibition by a novel steroid, mometasone furoate. Immunopharmacol Immunotoxicol. 1991, 13: 251-261. 10.3109\/08923979109019704.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1052_CR19","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0024-3205(02)01921-5","volume":"71","author":"X Zhang","year":"2002","unstructured":"Zhang X, Moilanen E, Adcock IM, Lindsay MA, Kankaanranta H: Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sci. 2002, 71: 1523-1534. 10.1016\/S0024-3205(02)01921-5.","journal-title":"Life Sci"},{"key":"1052_CR20","first-page":"648","volume":"118","author":"E Minshall","year":"1998","unstructured":"Minshall E, Ghaffar O, Cameron L, O'Brien F, Quinn H, Rowe-Jones J, Davies RJ, Prior A, Lund VJ, Mackay IS, Nolop K, Lutsky B, Durham SR, Hamid Q: Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg. 1998, 118: 648-654.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"1052_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000070218","volume":"130","author":"CE Baena-Cagnani","year":"2003","unstructured":"Baena-Cagnani CE, Berger WE, DuBuske LM, Gurn\u00e9 SE, Stryszak P, Lorber R, Danzing M: Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol. 2003, 130: 307-313. 10.1159\/000070218.","journal-title":"Int Arch Allergy Immunol"},{"key":"1052_CR22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1067\/mai.2003.168","volume":"111","author":"FE Simons","year":"2003","unstructured":"Simons FE, Prenner BM, Finn A, Desloratadine Study Group: Efficacy and safety of desloratadine in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2003, 111: 617-622. 10.1067\/mai.2003.168.","journal-title":"J Allergy Clin Immunol"},{"key":"1052_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1034\/j.1600-0625.2000.009002118.x","volume":"9","author":"U Lippert","year":"2000","unstructured":"Lippert U, M\u00f6ller A, Welker P, Artuc M, Henz BM: Inhibition of cytokine secretion from human leukemic mast cells and basophils by H1- and H2-receptor antagonists. Exp Dermatol. 2000, 9: 118-124. 10.1034\/j.1600-0625.2000.009002118.x.","journal-title":"Exp Dermatol"},{"key":"1052_CR24","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1046\/j.1365-2222.2001.01130.x","volume":"31","author":"JT Schroeder","year":"2001","unstructured":"Schroeder JT, Schleimer RP, Lichtenstein LM, Kreutner W: Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy. 2001, 31: 1369-1377. 10.1046\/j.1365-2222.2001.01130.x.","journal-title":"Clin Exp Allergy"},{"key":"1052_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","volume":"63","author":"J Bousquet","year":"2008","unstructured":"Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Canonica GW, van Weel C, Agache I, A\u00eft-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D, World Health Organization; GA(2)LEN; AllerGen: Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008, 63: 8-160. 10.1111\/j.1398-9995.2007.01620.x.","journal-title":"Allergy"},{"key":"1052_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1081-1206(10)60452-8","volume":"100","author":"R Anolik","year":"2008","unstructured":"Anolik R: Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008, 100: 264-271. 10.1016\/S1081-1206(10)60452-8.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"1052_CR27","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1046\/j.1365-2222.1999.00598.x","volume":"29","author":"F Purello-D'Ambrosio","year":"1999","unstructured":"Purello-D'Ambrosio F, Isola S, Ricciardi L, Gangemi S, Barresi L, Bagnato GF: A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES). Clin Exp Allergy. 1999, 29: 1143-1147.","journal-title":"Clin Exp Allergy"},{"key":"1052_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1365-2222.2004.01877.x","volume":"34","author":"G Di Lorenzo","year":"2004","unstructured":"Di Lorenzo G, Pacor ML, Pellitteri ME, Morici G, Di Gregoli A, Lo Bianco C, Ditta V, Martinelli N, Candore G, Mansueto P, Rini GB, Corrocher R, Caruso C: Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004, 34: 259-267. 10.1111\/j.1365-2222.2004.01877.x.","journal-title":"Clin Exp Allergy"},{"key":"1052_CR29","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.anl.2007.06.004","volume":"35","author":"E Pinar","year":"2008","unstructured":"Pinar E, Eryigit O, Oncel S, Calli C, Yilmaz O, Yuksel H: Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis. Auris Nasus Larynx. 2008, 35: 61-66. 10.1016\/j.anl.2007.06.004.","journal-title":"Auris Nasus Larynx"},{"key":"1052_CR30","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1398-9995.1996.tb04622.x","volume":"51","author":"L Crampette","year":"1996","unstructured":"Crampette L, Mainprice B, Bloom M, Bousquet J, Campbell AM: Inhibition of mediator and cytokine release from dispersed nasal polyp cells by terfenadine. Allergy. 1996, 51: 346-349.","journal-title":"Allergy"},{"key":"1052_CR31","first-page":"421","volume":"8","author":"E Berti","year":"1998","unstructured":"Berti E, Cerri A, Marzano AV, Richelda R, Bianchi B, Caputo R: Mometasone furoate decreases adhesion molecule expression in psoriasis. Eur J Dermatol. 1998, 8: 421-426.","journal-title":"Eur J Dermatol"},{"key":"1052_CR32","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1094-5539(03)00068-3","volume":"16","author":"F Sabatini","year":"2003","unstructured":"Sabatini F, Silvestri M, Sale R, Serpero L, Giuliani M, Scarso L, Favini P, Rossi GA: Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling. Pulm Pharmacol Ther. 2003, 16: 287-297. 10.1016\/S1094-5539(03)00068-3.","journal-title":"Pulm Pharmacol Ther"},{"key":"1052_CR33","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1600-0625.1995.tb00257.x","volume":"4","author":"U Lippert","year":"1995","unstructured":"Lippert U, Kr\u00fcger-Krasagakes S, M\u00f6ller A, Kiessling U, Czarnetzki BM: Pharmacological modulation of IL-6 and IL-8 secretion by the H1-antagonist decarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol. 1995, 4: 272-276. 10.1111\/j.1600-0625.1995.tb00257.x.","journal-title":"Exp Dermatol"},{"key":"1052_CR34","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s00011-004-1309-6","volume":"53","author":"Y Zhao","year":"2004","unstructured":"Zhao Y, Leung PC, Woo KS, Chen GG, Wong YO, Liu SX, van Hasselt CA: Inhibitory effects of budesonide, desloratadine and dexamethasone on cytokine release from human mast cell line (HMC-1). Inflamm Res. 2004, 53: 664-669. 10.1007\/s00011-004-1309-6.","journal-title":"Inflamm Res"},{"key":"1052_CR35","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1164\/ajrccm.164.4.2007063","volume":"164","author":"MD Inman","year":"2001","unstructured":"Inman MD, Watson RM, Rerecich T, Gauvreau GM, Lutsky BN, Stryszak P, O'Byrne PM: Dose-dependent effects of inhaled mometasone furoate on airway function and inflammation after allergen inhalation Challenge. Am J Respir Crit Care Med. 2001, 164: 569-574.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-12-23\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:17:52Z","timestamp":1630502272000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-12-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1052"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-12-23","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"6 October 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}